Key result
Among children and young adults treated with amiodarone, 17.3% developed subclinical hypothyroidism, 13.7% developed hypothyroidism, and 2.1% developed hyperthyroidism.
Why the study?
Because the onset of amiodarone-induced thyrotoxicosis and hypothyroidism had not been studied in children, the timing of dysfunction and long-term monitoring were unknown.
What is the prevalence and timing of amiodarone-induced thyroid dysfunction in pediatric and young adult patients?
Observational (n=484)
No
What is the prevalence and timing of amiodarone-induced thyroid dysfunction in pediatric and young adult patients?
Amiodarone frequently causes thyroid dysfunction in pediatric and young adult patients, primarily within the first 35 days of treatment, supporting recommendations for weekly thyroid monitoring during the first 5 weeks of therapy.
Answers are grounded in this paper and cite their sources.
May support early thyroid monitoring in young amiodarone recipients; observational data leaves open optimal strategies and causal confirmation.
CONTEXT: Amiodarone is used in patients with arrhythmias, but thyroid dysfunction [amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH)] is a common adverse effect. As the onset of AIT and AIH has not been studied in children, the timing of dysfunction and long-term monitoring are not known in this population. OBJECTIVE: To describe the incidence and timing of amiodarone-induced thyroid dysfunction in children and adolescents, with a secondary aim to identify risk factors for amiodarone-induced thyroid dysfunction, and to identify variance in thyroid hormone surveillance and treatment. DESIGN: Retrospective review of thyroid dysfunction in children and young adults treated with amiodarone between 2007 and 2018. SETTING: Children's Hospital of Philadelphia. PATIENTS: Children and young adults treated with amiodarone. MAIN OUTCOME MEASURES: Prevalence of amiodarone-induced thyroid dysfunction. RESULTS: Of 484 patients, 190 had thyroid-function testing; 17.3% were found to have subclinical hypothyroidism, and 13.7% testing developed hypothyroidism. Hyperthyroidism occurred in 2.1%. In patients with subclinical hypothyroidism, 63% returned to normal thyroid function without thyroid hormone replacement. Only 26% of patients with hypothyroidism had spontaneous normalization of thyroid function. Twenty-five percent of AIT patients had spontaneous normalization of thyroid function. CONCLUSIONS: This study looks at a pediatric and young-adult population in an effort to describe the natural history of amiodarone-induced thyroid dysfunction. Based on our data, we recommend that a complete thyroid-function panel be obtained within the first week and then at weekly intervals for the first 5 weeks after initiation. The majority of thyroid dysfunction was noted within the first 35 days of treatment.
No takes yet. Share an insight, caveat, or question.
Barrett et al. (2019) conducted an observational in Arrhythmias (n=484). Amiodarone was evaluated on Prevalence of amiodarone-induced thyroid dysfunction. Among children and young adults treated with amiodarone, 17.3% developed subclinical hypothyroidism, 13.7% developed hypothyroidism, and 2.1% developed hyperthyroidism.
Synapse has enriched 10 related papers. Consider them for comparative context: